Year: 2020

Why we’re giving $250 million more to fight COVID-19

In the pandemic’s first year, the work of ending the pandemic was confined to a relatively small domain: Labs and clinical trials

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, for its COVID-19 vaccine, which was co-developed with scientists at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID).